Saneca Pharmaceuticals made a net profit of EUR -3.60 mil in 2019, up 0% compared to the previous year. Historically, between 2014 and 2019, the company's net profit reached a high of EUR 6.60 mil in 2014 and a low of EUR -3.60 mil in 2019.
The result implies a return on equity of -14.8% and a return on invested capital of -9.48% in 2019. That is compared to an average of -7.39% and -4.74% over the last five years.
The company has been operating with average EBITDA margin of 1.01% in the last 5 years and an average net margin of -3.13%.
Since 2014, the firm's net profit increased by -155% or an average of % a year.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
